SE7904163L - PROCEDURES AND INTERMEDIATE PRODUCTS OF AT-125 - Google Patents

PROCEDURES AND INTERMEDIATE PRODUCTS OF AT-125

Info

Publication number
SE7904163L
SE7904163L SE7904163A SE7904163A SE7904163L SE 7904163 L SE7904163 L SE 7904163L SE 7904163 A SE7904163 A SE 7904163A SE 7904163 A SE7904163 A SE 7904163A SE 7904163 L SE7904163 L SE 7904163L
Authority
SE
Sweden
Prior art keywords
analogues
amino
procedures
nr14r15
alkyl
Prior art date
Application number
SE7904163A
Other languages
Swedish (sv)
Other versions
SE448376B (en
Inventor
R C Kelly
W Wierenga
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE7904163L publication Critical patent/SE7904163L/en
Publication of SE448376B publication Critical patent/SE448376B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Analogues of AT-125 having the formula <IMAGE> wherein R is hydrogen, alkyl, haloalkyl or aralkyl; X is halogen, alkoxy, alkylthio, aryloxy, arylthio, aralkoxy, aralkythio, amino, alkylamino or dialkylamino; and NR14R15 is amino or a blocked amino group, provided that X is not chlorine when R is hydrogen or alkyl and R14 or R15 is alkoxycarbonyl or NR14R15 is phthalimido. The analogues can have therapeutic activity. AT-125 and the analogues can be prepared by halogenation of a corresponding analogue of tricholomic acid.
SE7904163A 1978-05-15 1979-05-11 PROCEDURE FOR THE PREPARATION OF (ALFAS, 55) -ALFA-AMINO-3-CHLORO-2-ISOXAZOLINE-5-ETHIC ACID (AT-125) AND ANALOGS THEREOF SE448376B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90596378A 1978-05-15 1978-05-15

Publications (2)

Publication Number Publication Date
SE7904163L true SE7904163L (en) 1979-11-16
SE448376B SE448376B (en) 1987-02-16

Family

ID=25421749

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7904163A SE448376B (en) 1978-05-15 1979-05-11 PROCEDURE FOR THE PREPARATION OF (ALFAS, 55) -ALFA-AMINO-3-CHLORO-2-ISOXAZOLINE-5-ETHIC ACID (AT-125) AND ANALOGS THEREOF
SE8501965A SE8501965L (en) 1978-05-15 1985-04-23 PROCEDURES AND INTERMEDIATES FOR MANUFACTURING AT-125

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8501965A SE8501965L (en) 1978-05-15 1985-04-23 PROCEDURES AND INTERMEDIATES FOR MANUFACTURING AT-125

Country Status (10)

Country Link
JP (1) JPS54148781A (en)
AU (1) AU526380B2 (en)
BE (1) BE876261A (en)
CH (1) CH646961A5 (en)
DE (1) DE2918878A1 (en)
FR (1) FR2426049A1 (en)
GB (1) GB2023135B (en)
IT (1) IT1116816B (en)
NL (1) NL7903771A (en)
SE (2) SE448376B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643807A (en) * 1985-12-13 1987-02-17 The Dow Chemical Company Process for electrochemically forming an aromatic compound containing one or more alpha-acyloxylated aliphatic substitutent(s)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856807A (en) * 1972-03-13 1974-12-24 Upjohn Co L-({60 s,5s)-{60 -amino-3-chloro-2-isoxazoline-5-acetic acid
US3878047A (en) * 1973-02-02 1975-04-15 Upjohn Co Process for production of AT-125
US3944562A (en) * 1974-04-17 1976-03-16 The Upjohn Company αS, 4S, 5R α-Amino-3-chloro-4-hydroxy-2-isoxazoline-5-acetic acid

Also Published As

Publication number Publication date
GB2023135B (en) 1982-08-25
AU4672379A (en) 1979-11-22
JPS54148781A (en) 1979-11-21
NL7903771A (en) 1979-11-19
BE876261A (en) 1979-11-16
GB2023135A (en) 1979-12-28
SE448376B (en) 1987-02-16
AU526380B2 (en) 1983-01-06
SE8501965D0 (en) 1985-04-23
SE8501965L (en) 1985-04-23
CH646961A5 (en) 1984-12-28
IT1116816B (en) 1986-02-10
FR2426049B1 (en) 1983-06-17
DE2918878A1 (en) 1979-11-22
FR2426049A1 (en) 1979-12-14
IT7949040A0 (en) 1979-05-14

Similar Documents

Publication Publication Date Title
ATE68180T1 (en) MORPHOLINOETHYLESTER OF MYCOPHENOL ACID AND ITS DERIVATIVES, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS.
JPS552693A (en) 1*22dihydrooquinolinee22one derivative*its manufacture and allurgic affection therapeutic drug containing it
ATE116637T1 (en) SULFONIC STILBEN DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES.
ATE18197T1 (en) 1&#39;-AETHOXYCARBONYLOXYAETHYLESTER OF VALPONIC ACID, ITS PREPARATION AND FORMULATIONS CONTAINING THEM.
ATE159251T1 (en) TROPOLONE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS THEREOF FOR THE PREVENTION AND TREATMENT OF ISCHEMIC DISEASES
ES2068216T3 (en) TIENOTRIAZOLODIAZEPINE COMPOUNDS AND PHARMACEUTICAL USES THEREOF.
DE58905079D1 (en) NEW ALPHA-AMINOCARBONIC ACID DERIVATIVES, THEIR PRODUCTION AND USE.
SE7904163L (en) PROCEDURES AND INTERMEDIATE PRODUCTS OF AT-125
NZ182556A (en) Tricylick azacyloalkanones
DE3787844T2 (en) Thioester and its use in the manufacture of pharmaceutical compositions for the treatment of ischemia and reperfusion syndromes.
ES2084460T3 (en) NEW DERIVATIVES OF ACID 7-ETHINYL-ALPHA- (METOXIMETILEN) -1-NAFTALENE ACETICO, ITS PREPARATION PROCEDURE AND ITS APPLICATION AS PESTICIDES.
DK422183D0 (en) PROCEDURE FOR PREPARING 5-HALOGENVINYL-2 &#39;-DEOXYURIDE INGREDIATES
JPS54128588A (en) Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
NO164352C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMASOYTIC ACTIVE, ANTIVIRAL, SUBSTITUTED ISOXSAZOL DERIVATIVES.
DE69107080T2 (en) Organotin compounds with anti-tumor activity and compositions with anti-tumor activity.
NO870950L (en) PROCEDURE FOR THE MANUFACTURE OF A STABLE INJECTABLE PHARMACEUTICAL PREPARATION.
ZA794030B (en) Aryl sulfinic acid derivatives of aliphatic,aromatic or heterocyclic compounds
FI793705A (en) URETANDERIVAT
JPS5416469A (en) Organic phosphoric ester and acaricide containing the same
ES469450A1 (en) Benzylpyrimidine derivatives
FI904033A0 (en) NYA 1,3-OXAZINER.
JPS5382761A (en) Novel maphthyl propionic acid ester derivs.
JPS5439017A (en) Novel organic sulfonic acid esters and their preparation
SE7703284L (en) PREPARATION OF ISOXAZOLO (3,4-D) PYRIMIDINES
SE8702697L (en) PREPARATION OF MEDICINAL PRODUCTS FOR TREATMENT OF ISCHEMIC Vascular Diseases

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7904163-8

Effective date: 19900518

Format of ref document f/p: F